Study will assess HMA and KIT inhibitors to treat SM subtype
A new study will examine a treatment for patients with systemic mastocytosis with an associated hematologic neoplasm.
A new study will examine a treatment for patients with systemic mastocytosis with an associated hematologic neoplasm.
A recent case report details a patient with mast cell leukemia (MCL), which authors state may be the rarest form of systemic mastocytosis (SM).
Desensitization to isatuximab allergy in patients with ISM appears possible, according to a recent report.